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Abstract
Objectives
Numerous genetic loci have been associated with measures of central fat accumulation,
such as waist-to-hip ratio adjusted for body mass index (WHRadjBMI). However the mecha-
nisms by which genetic variations influence obesity remain largely elusive. Lipolysis is a
key process for regulation of lipid storage in adipocytes, thus is implicated in obesity and its
metabolic complications. Here, genetic variants at 36 WHRadjBMI-associated loci were
examined for their influence on abdominal subcutaneous adipocyte lipolysis.
Subjects and Methods
Fasting subcutaneous adipose tissue biopsies were collected from 789 volunteers (587
women and 202 men, body mass index (BMI) range 17.7–62.3 kg/m2). We quantified
subcutaneous adipocyte lipolysis, both spontaneous and stimulated by the catecholamine
isoprenaline or a cyclic AMP analogue. DNA was extracted from peripheral blood mononu-
clear cells and genotyping of SNPs associated with WHRadjBMI conducted. The effects on
adipocyte lipolysis measures were assessed for SNPs individually and combined in a SNP
score.
Results
TheWHRadjBMI-associated loci CMIP, PLXND1, VEGFA and ZNRF3-KREMEN1 demon-
strated nominal associations with spontaneous and/or stimulated lipolysis. Candidate
genes in these loci have been reported to influence NFκB-signaling, fat cell size andWnt
signalling, all of which may influence lipolysis.
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Significance
This report provides evidence for specific WHRadjBMI-associated loci as candidates to
modulate adipocyte lipolysis. Additionally, our data suggests that genetically increased cen-
tral fat accumulation is unlikely to be a major cause of altered lipolysis in abdominal
adipocytes.
Introduction
With an almost epidemic global increase in obesity [1], related complications including type 2
diabetes and cardiovascular disease are a growing burden on healthcare systems. However, it
has become clear that the distribution of fat tissue and the function of adipose tissue, rather
than the amount of fat per se, exert an important impact [2, 3]. In particular, central fat accu-
mulation, reflected by high waist-to-hip ratio (WHR), is strongly associated with risk for type 2
diabetes and other complications [3].
There is a strong genetic component influencing fat distribution. WHR adjusted for body
mass index (WHRadjBMI) can be considered as a measure of fat distribution independent of
overall obesity [4]. Recent genome wide association studies (GWAS) have identified several
genetic loci associated with WHRadjBMI [4–6]. These findings notwithstanding, the identity
of both the culprit genes in the loci and the mechanisms by which they influence adipose func-
tion or clinical phenotypes remain unclear. Importantly, whereas central regulation of food
intake is believed to be a major determinant of overall obesity and BMI [7], it seems likely that
fat distribution, as assessed by WHR, is primarily regulated locally in adipose tissue. In support
of this, many genes at WHRadjBMI-associated loci are expressed in adipose tissue [8]. In addi-
tion, a few genes at these loci have recently been shown to be differentially expressed between
subcutaneous and visceral adipose tissue compatible with a depot specific function [8].
A major function of adipose tissue is to store and release adipocyte fatty acids through ester-
ification to triglycerides and hydrolysis of these triglycerides (lipolysis) according to the body’s
energy demands. Disturbances in adipocyte lipolysis have been associated with abdominal obe-
sity and WHR [9, 10]. Increased spontaneous lipolysis provides excess amounts of fatty acids
which, in turn, induce insulin resistance [11, 12]. It is well established that the ability of cate-
cholamines to stimulate lipolysis is blunted in obese individuals [13]. These subjects may retain
lipids in adipocytes and thereby expand adipose tissue since the triglycerides within adipocytes
constitute>90% of adipocyte volume and is the major volume component of the adipose
mass.
Herein, we tested the hypothesis that genetic variation in WHRadjBMI-associated loci influ-
ence fat cell lipolysis. We utilized a unique large patient cohort in which both spontaneous and
catecholamine-stimulated subcutaneous abdominal adipocyte lipolysis was measured.
Subjects and Methods
Cohort description
Characteristics of the study population are presented in Table 1. Adult subjects with a large
inter-individual variation in body mass index (BMI, range 17.7–62.3 kg/m2, 587 women and
202 men) were recruited by local advertisement. All participants were examined at 8 a.m. after
an overnight fast. A trained research nurse collected information about body weight, height,
waist, and hip circumferences. A venous blood sample was obtained for routine laboratory
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measurements and extraction of DNA. Finally, a subcutaneous adipose tissue biopsy was
obtained by needle aspiration under local anesthesia from the abdominal region. All subjects
were of European origin, were healthy except for obesity, and were not taking any medication.
For consistency with the previous reports [4–6], WHRadjBMI was calculated in a sex-specific
manner by inverse-normal transformation of the residuals of the linear regression model:
WHR adjusted for age, age2 and BMI [4]. The study was approved by the regional Ethics Com-
mittee in Stockholm and all subjects gave their written informed consent to participation.
Lipolysis experiments
The adipose tissue specimens were brought to the laboratory, rinsed repeatedly in saline and
visual blood vessels and cell debris were removed. Spontaneous or unstimulated lipolytic activ-
ity was determined in explants of adipose tissue as described [12]. In brief, pieces of adipose tis-
sue (200 or 300 mg) were incubated for 2 h as described below (100 mg/ml). Glycerol release
into the medium was measured using a sensitive bioluminescence method and expressed as
amount of glycerol release per 2 h and 107 adipocytes [12]. Adipocytes are the only source of
glycerol which is an end product of lipolysis.
The remaining tissue (about 1 gram) was subjected to collagenase treatment as described
[14] to obtain isolated adipocytes. Measurement of stimulated lipolysis in isolated adipocytes
was investigated as previously described [15]. Diluted cell suspensions (2% v/v) were incubated
in duplicate for 2 h at 37°C with air as the gas phase in Krebs–Ringer phosphate buffer (pH
7.4) supplemented with glucose (8.6 mmol/l), ascorbic acid (0.1 mg/ml) and bovine serum
albumin (20 mg/ml), without (basal) or with increasing concentrations (10−9–10−5 mol/l) of
the synthetic non-selective β1, β2 and β3-adrenoreceptor agonist isoprenaline (Hässle, Möln-
dal, Sweden), or 10−5 to 10−3 mol/l of dibutyryl cyclic AMP (dcAMP, Sigma-Aldrich, Stock-
holm, Sweden), which is a phosphodiesterase-resistant cyclic AMP analogue that activates the
cyclic AMP-dependent protein kinase A (S1 Fig). Variations in the lipolytic action of the non-
metabolizing dcAMP can only be explained by variations in lipolysis activation at, or beyond,
the level of cAMP-dependent protein kinase A, whereas lipolysis variation of isoprenaline can
be explained at any step in catecholamine stimulated lipolysis, from beta-adrenoreceptors to
hormone sensitive lipase [13]. Stimulated lipolysis was expressed as the ratio of isoprenaline-
induced or dcAMP-induced amount of glycerol release per 2 h at maximum effective concen-
tration divided by basal glycerol release. We recently demonstrated that this measurement
correlates better with clinical phenotypes than expression of absolute rates of glycerol release
per adipocyte [16, 17].
Table 1. Cohort characteristics.
Sex Men Women
N 202 587
Age (years) 42 (14) 39 (10)
Height (m) 1.79 (0.07) 1.67 (0.07)
Waist (cm) 104 (20) 106 (21)
WHR 0.99 (0.07) 0.92 (0.09)
BMI (kg/m2) 29.6 (7.4) 33.8 (8.8)
Glucose (mmol/l) 5.38 (1.15) 5.26 (0.94)
Insulin (pmol/l) 12.7 (10.2) 11.6 (7.5)
Total cholesterol (mmol/l) 5.38 (1.34) 5.02 (1.05)
HDL cholesterol (mmol/l) 1.14 (0.33) 1.32 (0.36)
Where: WHR, waist:hip ratio; Values presented as mean (sd).
doi:10.1371/journal.pone.0153990.t001
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Selection and genotyping of WHRadjBMI-associated single nucleotide
polymorphisms
Single nucleotide polymorphisms (SNPs) tagging loci robustly associated with central fat accu-
mulation as measured by WHRadjBMI were identified from literature [4–6]. Where the same
locus is reported by multiple papers, the tag SNP was chosen from the first reported study. Due
to the multiplex format used for genotyping, proxies were used to tag 3 SNPs: rs4531856 was
used instead of rs12608504 (JUND) [6], rs1550280 instead of rs7830933 (NKX2-6) [6] and
rs2165295 instead of rs1440372 (SMAD6) [6] (r2 = 1/0.96/1 respectively, 1000 Genomes pilot
1, CEU data [18]). Genotyping was conducted in two rounds: initially SNPs reported by Heid
et al [4] and Randall et al [5], were analysed. Subsequently, SNPs reported by Shungin et al [6]
were genotyped (with an additional 100 subjects being included). Genotyping of 48
WHRadjBMI-associated loci was conducted using the MassARRAY system with the iPLEX
chemistry (Sequenom, San Diego, CA). Samples were analysed by matrix-assisted laser desorp-
tion-ionization time-of-flight (MALDI-TOF) mass spectrometry (Bruker Daltonik, Leipzig,
Germany). MassARRAY TYPER 4.0 software (Sequenom) was used for peak identification
within the mass spectra. One tagging SNP, rs9491696 (RSPO3, assay C___2789025_10), was
genotyped using the Taqman system (Applied Biosystems, Stockholm, Sweden) according to
the manufacturer’s instructions. Genotyping failed for tag SNPs in seven loci (KCNJ2
rs8066985; GORAB rs10919388; DCST2 rs905938; KLF13 rs8042543;HOXA11 rs7801581;
MACRD1-VEGFB rs11231693 [6]; CPEB4 rs6861681 [4]). The tag SNPs for 42 loci (Table 2)
were successfully genotyped. For five loci, genotype frequencies deviated significantly from
Hardy-Weinberg equilibrium (SNX10 rs1534696; NMU rs3805389; PEMT rs4646404; LY86
rs1294421; ITPR2-SSPN rs718314, (S1, Table)). Of these, two SNPs demonstrated very low het-
erozygous counts (LY86 rs1294421 and ITPR2-SSPN rs718314), possibly indicative of technical
issues with the assays, thus these SNPs were excluded from analysis. For three SNPs (SNX10
rs1534696, NMU rs3805389 and PEMT rs4646404) the genotype frequencies were skewed but
plausible, and possibly due to high rate of obesity in the studied cohort, thus these SNPs were
included in analyses. Thus 40 tag SNPs were further analysed (Table 2). Where Shungin et al
[6] report the same SNP as Heid et al [4], effect allele, effect allele frequency and effect sizes are
given from Shungin et al due to the larger sample size. Of note, Randall et al [5] and Shungin
et al [6] both report signals denoted asMAP3K1, however as the SNPs are>700Kb apart and
in incomplete linkage disequilibrium (r2 = 0.88 between rs11743303 and rs9687846 [18]) they
are both included in this report.
Statistical Methods
Correlations between raw phenotypes were assessed by Spearman rank coefficients. All vari-
ables were assessed for normality and where a skewed distribution was observed, natural log
transformed before further analysis. Statistical analyses were conducted in STATA (STATA-
corp LP, Texas, USA). For genetic analysis, linear regression was used to assess the effect of
SNPs on the traits of interest using additive models in PLINK [19]. As a sex effect was reported
for most tagging SNPs, sex-specific analyses were conducted, as well as a sex-combined analysis
including a SNP x sex interaction. Unweighted SNP scores were constructed by addition of the
number of reported WHRadjBMI-increasing alleles (Table 2). Analyses of lipolysis measures
were adjusted for sex, age, age2, and BMI as above for consistency and to enable comparison
between phenotypes. Under the assumption that the heritability of lipolysis is similar to that of
fat distribution [6], we have 99% power to detect an effect with nominal p value 0.05. False dis-
covery rate (FDR) was calculated according to Benjamini-Hochberg. Because the selection of
Fat Distribution Loci and Adipocyte Lipolysis
PLOS ONE | DOI:10.1371/journal.pone.0153990 April 22, 2016 4 / 12
Table 2. Characteristics of genotyped SNPs tagging 40 of 49 knownWHRadjBMI-associated loci.
CHR SNP Position Locus† First report EA Beta EAF Sex**
1 rs984222 119503843 TBX15-WARS2 Heid 2010 G 0.03 0.64 -
1 rs1011731 172346548 DNM3-PIGC Heid 2010 G 0.03 0.43 -
1 rs4846567 219750717 LYPLAL1 Heid 2010 G 0.03 0.72 F
2 rs1385167 66200648 MEIS1 Shungin 2015 G 0.03 0.15 -
2 rs10195252 165513091 GRB14-COBLL1‡ Heid 2010 T 0.03 0.60 F
3 rs4684854 12488882 PPARG Randall 2013 C 0.04 0.42 F
3 rs6784615 52506426 PBRM1 Heid 2010 T 0.04 0.94 -
3 rs6795735 64705365 ADAMTS9 Heid 2010 C 0.03 0.59 F
3 rs10804591 129334233 PLXND1 Shungin 2015 A 0.03 0.79 F
3 rs17451107 156797609 LEKR1 Shungin 2015 T 0.03 0.61 -
4 rs3805389 56482750 NMU Shungin 2015 A 0.01 0.28 F
4 rs9991328 89713121 FAM13A Shungin 2015 T 0.02 0.49 F
4 rs303084 124066948 SPATA5-FGF2 Shungin 2015 A 0.02 0.80 -
5 rs11743303 55859952 MAP3K1 Randall 2013 G 0.03 0.21 F
5 rs9687846 56566067 MAP3K1 Shungin 2015 A 0.02 0.19 F
5 rs10478424 118789020 HSD17B4 Randall 2013 A 0.04 0.78 F
5 rs6556301 176527577 FGFR4 Shungin 2015 T 0.02 0.36 -
6 rs7759742 32381736 BTNL2 Shungin 2015 A 0.02 0.51 -
6 rs1776897 34195011 HMGA1 Shungin 2015 G 0.03 0.08 F
6 rs6905288 43758873 VEGFA Heid 2010 A 0.04 0.56 F
6 rs9491696 127452639 RSPO3 Heid 2010 G 0.04 0.48 F
7 rs1055144 25871109 NFE2L3 Heid 2010 T 0.04 0.21 -
7 rs1534696 26397239 SNX10 Shungin 2015 C 0.01 0.43 F
8 rs1550280 23601830 NKX2-6* Shungin 2015 C 0.02 0.77 F
8 rs12679556 72514228 MSC Shungin 2015 G 0.03 0.25 -
9 rs10991437 107735920 ABCA1 Shungin 2015 A 0.03 0.11 -
10 rs7917772 104487443 SFXN2 Shungin 2015 A 0.01 0.62 F
12 rs1443512 54342684 HOXC13‡ Heid 2010 A 0.03 0.24 F
12 rs4765219 124440110 CCDC92 Shungin 2015 C 0.03 0.67 -
15 rs8030605 56504598 RFX7 Shungin 2015 A 0.03 0.14 -
15 rs2165295 67027320 SMAD6* Shungin 2015 A 0.02 0.71 -
16 rs2925979 81534790 CMIP Shungin 2015 T 0.02 0.31 F
17 rs4646404 17420199 PEMT Shungin 2015 G 0.03 0.67 -
18 rs12454712 60845884 BCL2 Shungin 2015 T 0.02 0.61 F
19 rs4531856 18388383 JUND* Shungin 2015 C 0.02 0.36 -
19 rs4081724 33824946 CEBPA Shungin 2015 G 0.04 0.85 -
20 rs979012 6623374 BMP2 Shungin 2015 T 0.03 0.34 -
20 rs224333 34023962 GDF5 Shungin 2015 G 0.02 0.62 M
20 rs6090583 45558831 EYA2 Shungin 2015 A 0.02 0.48 -
22 rs4823006 29451671 ZNRF3 Heid 2010 A 0.02 0.57 -
Where: WHRadjBMI, waist:hip ratio adjusted for body mass index calculated as per (Heid et al, 2010)
†, Locus name taken from Shungin et al; EA, reported effect or WHRadjBMI-increasing allele; β, reported effect size; reported EAF, effect allele frequency
*proxy used instead of reported tag SNP (rs1550280 instead of rs7830933, r2 = 0.96, rs2165295 instead of rs1440372, r2 = 1, rs4531856 instead of
rs12608504, r2 = 1), but EAF given for the reported tag SNP
‡, same SNP reported by Heid et al but Beta and EAF given from Shungin et al
-, no evidence for sex-speciﬁc effects; F, evidence supports a stronger effect in women; M, evidence suggests a stronger effect in men.
** sex speciﬁc evidence
doi:10.1371/journal.pone.0153990.t002
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SNPs is based on known associations with related biological traits adjustment for multiple test-
ing could be too conservative and a p value0.05 is reported together with FDRs.
Results
Relationships between measures of obesity and lipolysis
In order to test our hypothesis that central obesity influences lipolysis we first examined
whether measures of adipocyte lipolysis correlated with obesity measures. We investigated
spontaneous, isoprenaline- (activating β-adrenoceptors) and dcAMP- (activating protein
kinase A) stimulated lipolysis for correlations with the obesity phenotypes WHR, BMI and
WHRadjBMI. All assessed obesity phenotypes correlated positively with spontaneous lipolysis
but inversely with isoprenaline or dcAMP induced lipolysis (Table 3). As the tested variable
most accurately reflecting the accumulation of metabolically detrimental fat independent of
overall obesity [4], we focused on WHRadjBMI for further analyses.
Effect of WHRadjBMI-associated SNPs on lipolysis
Whether altered lipolysis causes or results from central fat accumulation remains unclear. Here,
a Mendelian randomisation experiment was performed to test causality by using SNPs tagging
40 loci robustly associated withWHRadjBMI [4–6]. If central obesity regulates lipolysis
(increased spontaneous lipolysis and/or reduced stimulated lipolysis) then it would be expected
that SNPs robustly associated with increased central obesity would demonstrate consistent effects
on lipolysis phenotypes. TheWHRadjBMI-increasing allele previously reported [4–6] is taken as
the trueWHRadjBMI-increasing allele, and is referred to as such in the further analyses. The
SNP scores were calculated by summing the number of WHRadjBMI-increasing alleles, and thus
represent the genetic burden or predisposition to increased central obesity. Only subjects success-
fully genotyped for all SNPs included in the score were considered in the analysis. The SNP
scores including all 40 tagging SNPs demonstrated no associations with all tested measures of
lipolysis (Table 4). To exclude pleiotropic effects, a SNP score was calculated excluding SNPs
(rs17451107, rs1195252, rs2925979, rs303084, rs4765219, rs4846567, rs9687846 and rs998584)
with known effects on related traits, namely levels of HDL, LDL, TG or adiponectin and birth-
weight, which also revealed no associations with lipolysis measures (Table 4). It should be noted
that for a larger cohort of 331–556 subjects (depending on phenotype) in which we assessed
scores for the 14 loci known [4–5] prior to the recent Shungin et al report [6], we found a similar
lack of association with the adipose lipolysis measures (S2 Table).
It is possible that some SNPs influence mechanisms leading to central fat accumulation but
that their effects might be diluted when all SNPs are combined into the SNP score. Therefore
Table 3. Spearman rank correlations of obesity phenotypes with adipocyte lipolysis measures.
WHR BMI WHRadjBMI
N Rho P N Rho P N Rho P
Spontaneous lipolyis 461 0.267 <0.0001 470 0.398 <0.0001 461 0.157 0.0007
Isoprenaline-stimulated lipolysis* 710 -0.299 <0.0001 731 -0.319 <0.0001 710 -0.152 <0.0001
dcAMP-stimulated lipolysis* 712 -0.284 <0.0001 712 -0.296 <0.0001 712 -0.134 0.0003
Where: WHR, waist:hip ratio; WHRadjBMI, WHR adjusted for BMI, calculated as per (Heid et al, 2010); Spontaneous lipolysis, mmol/glycerol per 2 hours
and 107 cells; dcAMP, dibutyryl cyclic AMP
* divided by basal lipolysis measures.
doi:10.1371/journal.pone.0153990.t003
Fat Distribution Loci and Adipocyte Lipolysis
PLOS ONE | DOI:10.1371/journal.pone.0153990 April 22, 2016 6 / 12
we tested individual WHRadjBMI-associated SNPs for influence on measures of spontaneous and
stimulated lipolysis (Table 5). Nominally significant associations with spontaneous lipolysis were
detected for two loci in which theWHRadjBMI-increasing allele was associated with an increased
rate of lipolysis (PLXND1 rs10804591 and CMIP rs2925979). Moreover, two loci demonstrated
effects on isoprenaline-stimulated lipolysis, with theWHRadjBMI-increasing allele being associ-
ated with increased lipolysis (VEGFA rs6905288 and ZNRF3-KREMEN1 rs4823006). Finally, the
WHRadjBMI-increasing allele of rs4823006 (ZNRF3-KREMEN1) was associated with increased
dcAMP-stimulated lipolysis, whilst theWHRadjBMI-increasing allele of rs2925979 (CMIP) was
associated with decreased dcAMP-stimulated lipolysis. None of these genetic associations were
significant with FDR<5% after adjustment for the analysis of multiple SNPs (Table 5).
Influence of individual WHR-adjBMI-associated genetic variants on
central obesity
To determine whether the SNP effects onWHRadjBMI in our study concurred with those
reported previously, linear regression analyses was conducted. Of 40 SNPs analysed here, 24 of
the reported WHRadjBMI-increasing alleles demonstrated the expected positive effect on
WHRadjBMI in this cohort, and 7 SNPs demonstrated the expected effect size (Table 6) [4–6].
For most complex quantitative traits studied to date, maximum effect sizes of ~0.05 have been
reported. Thus, the effect sizes of 32 SNPs, even if differing slightly from those previously
reported, are unsurprising whilst the 8 SNPs with effect sizes larger than 0.05 should be inter-
preted with caution (Table 6) [4–6]. These inconsistencies might be due to the relative small
sample size of subjects available here (n = approximately 750 compared to the reported
n = 210,000 [6]), the enrichment for obese subjects in the here analysed study population, or
the relative numbers of men and women (n = 202 and n = 587 respectively). The male-specific
analysis shows effect sizes rather larger than those previously observed [6], but the relatively
small sample size (n = 202) means that this is likely a spurious result.
Discussion
Whilst a plethora of genetic variants associated with measures of obesity have been identified,
the modulated molecular mechanisms underpinning poor metabolic regulation remain elusive.
Table 4. Linear regression analysis of the effect of theWHRadjBMI-increasing SNPscore on lipolysis phenotypes.
40SNPscore 40SNPscore no pleiotropy**
N adjR2 Beta Se L95 U95 Pmain Pinter N adjR2 Beta Se L95 U95 Pmain Pinter
Spontaneous
lipolysis
174 0.23 0.012 0.010 -0.008 0.032 0.2370 0.7800 174 0.22 0.006 0.011 -0.016 0.028 0.6090 0.8080
Isoprenaline-
stimulated
lipolysis*
305 0.17 -0.001 0.004 -0.009 0.006 0.7010 0.2290 305 0.17 0.001 0.004 -0.007 0.009 0.7860 0.1480
dcAMP-
stimulated
lipolysis*
294 0.15 -0.004 0.004 -0.013 0.004 0.2870 0.2140 294 0.14 -0.002 0.005 -0.011 0.007 0.6270 0.1680
Where: adjR2, adjusted R2 from regression models; L95, lower boundry of 95% conﬁdence interval; U95, upper boundry of 95% conﬁdence interval;
Pmain, P value for main effect; Pinter, Pvalue for sex interaction
* compared to basal lipolysis levels
**SNP score excluding variants rs17451107, rs1195252, rs2925979, rs303084, rs4765219, rs4846567, rs9687846 and rs998584 which previously have
been associated with related traits, namely levels of HDL, LDL, TG or adiponectin and birthweight
doi:10.1371/journal.pone.0153990.t004
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WHR, when adjusted for BMI (WHRadjBMI [4]), has been proposed as representative of cen-
tral fat accumulation independent of total obesity. Here we used WHRadjBMI-associated loci
to investigate whether genetically determined central fat accumulation controls lipolysis
Table 6. Effect of SNPs tagging central obesity-associated loci onWHRadjBMI.
All subjects (n = 516–739) Women (n = 425–558) Men (n = 142–181) Pinter
SNP Locus EA Beta Se L95 U95 P Beta Se L95 U95 P Beta Se L95 U95 P
rs984222† TBX15-WARS2 G 0.07 0.06 -0.04 0.18 0.2238 0.08 0.07 -0.05 0.21 0.2551 0.06 0.11 -0.16 0.28 0.5831 0.8411
rs1011731†* DNM3-PIGC G 0.03 0.06 -0.08 0.14 0.6106 0.01 0.07 -0.11 0.14 0.8213 0.06 0.11 -0.15 0.27 0.5680 0.7299
rs4846567† LYPLAL1 G 0.13 0.06 0.02 0.25 0.0209 0.21 0.07 0.07 0.34 0.0025 -0.08 0.11 -0.29 0.14 0.4708 0.0273
rs1385167 MEIS1 G -0.01 0.07 -0.15 0.13 0.8669 -0.06 0.08 -0.21 0.10 0.4774 0.16 0.15 -0.14 0.45 0.3051 0.2118
rs10195252 GRB14-COBLL1 T 0.00 0.06 -0.11 0.12 0.9478 0.00 0.07 -0.13 0.13 0.9898 0.02 0.11 -0.19 0.23 0.8493 0.9264
rs4684854† PPARG C 0.02 0.06 -0.09 0.13 0.6948 0.09 0.06 -0.04 0.21 0.1610 -0.25 0.12 -0.48 -0.02 0.0343 0.0138
rs6784615†* PBRM1 T 0.04 0.13 -0.21 0.29 0.7480 -0.07 0.14 -0.35 0.21 0.6325 0.46 0.29 -0.10 1.02 0.1118 0.0834
rs6795735 ADAMTS9 C -0.01 0.06 -0.12 0.10 0.7964 0.01 0.06 -0.12 0.14 0.8839 -0.08 0.11 -0.30 0.14 0.4650 0.5088
rs10804591† PLXND1 A 0.12 0.07 -0.01 0.25 0.0687 0.17 0.08 0.02 0.32 0.0258 0.01 0.12 -0.23 0.26 0.9153 0.2089
rs17451107† LEKR1 T 0.02 0.06 -0.09 0.13 0.7508 0.02 0.06 -0.11 0.14 0.7758 0.04 0.11 -0.17 0.25 0.7044 0.8555
rs3805389† NMU A 0.02 0.06 -0.10 0.14 0.7531 -0.05 0.07 -0.20 0.09 0.4632 0.24 0.13 -0.01 0.48 0.0660 0.0471
rs9991328† FAM13A T 0.04 0.05 -0.06 0.15 0.4324 0.05 0.06 -0.08 0.17 0.4727 0.03 0.11 -0.18 0.24 0.7749 0.7202
rs303084† SPATA5-FGF2 A 0.01 0.07 -0.12 0.14 0.8995 0.04 0.08 -0.11 0.19 0.5795 -0.09 0.14 -0.37 0.18 0.5006 0.3785
rs11743303† MAP3K1 G 0.07 0.07 -0.08 0.21 0.3613 0.01 0.09 -0.16 0.19 0.8839 0.15 0.13 -0.11 0.41 0.2539 0.2706
rs9687846* MAP3K1 A -0.02 0.07 -0.17 0.12 0.7576 -0.06 0.09 -0.23 0.11 0.5197 0.02 0.14 -0.25 0.29 0.8889 0.5133
rs10478424 HSD17B4 A -0.03 0.07 -0.17 0.10 0.6213 0.06 0.08 -0.09 0.22 0.4145 -0.37 0.14 -0.64 -0.10 0.0083 0.0082
rs6556301† FGFR4 T 0.01 0.05 -0.09 0.12 0.8117 -0.03 0.06 -0.15 0.10 0.6838 0.17 0.11 -0.04 0.38 0.1233 0.1179
rs7759742†* BTNL2 A 0.02 0.05 -0.09 0.12 0.7580 0.07 0.06 -0.04 0.19 0.2246 -0.16 0.10 -0.35 0.04 0.1148 0.0809
rs1776897† HMGA1 G 0.17 0.10 -0.03 0.38 0.0921 0.09 0.12 -0.15 0.33 0.4545 0.37 0.19 0.00 0.73 0.0537 0.1932
rs6905288† VEGFA A 0.03 0.06 -0.08 0.14 0.5458 0.05 0.07 -0.08 0.18 0.4494 0.00 0.11 -0.21 0.21 0.9842 0.6982
rs9491696† RSPO3 G 0.01 0.06 -0.10 0.12 0.8768 0.02 0.07 -0.11 0.15 0.7881 0.00 0.10 -0.21 0.20 0.9953 0.8313
rs1534696* SNX10 C -0.01 0.06 -0.13 0.10 0.8280 -0.01 0.07 -0.14 0.12 0.9015 -0.03 0.12 -0.27 0.22 0.8296 0.8925
rs1055144†* NFE2L3 T 0.04 0.07 -0.10 0.18 0.5450 0.06 0.08 -0.10 0.22 0.4716 -0.04 0.15 -0.34 0.26 0.8074 0.6040
rs1550280* NKX2-6 C -0.02 0.06 -0.14 0.11 0.7898 0.01 0.07 -0.13 0.15 0.9223 -0.05 0.13 -0.31 0.20 0.6758 0.4796
rs12679556† MSC G 0.11 0.06 -0.01 0.24 0.0775 0.11 0.07 -0.04 0.26 0.1377 0.14 0.12 -0.10 0.39 0.2477 0.7434
rs10991437 ABCA1 A -0.01 0.08 -0.16 0.14 0.9265 -0.06 0.09 -0.24 0.11 0.4856 0.19 0.14 -0.10 0.47 0.1960 0.1407
rs7917772† SFXN2 A 0.04 0.06 -0.07 0.15 0.4429 0.03 0.07 -0.10 0.16 0.6470 0.02 0.11 -0.19 0.23 0.8552 0.7680
rs1443512 HOXC13 A -0.01 0.06 -0.13 0.12 0.9304 0.01 0.07 -0.13 0.16 0.8776 -0.05 0.13 -0.31 0.20 0.6791 0.7217
rs4765219†* CCDC92 C 0.03 0.06 -0.08 0.14 0.6315 0.04 0.06 -0.08 0.17 0.4897 -0.01 0.11 -0.22 0.20 0.9266 0.6091
rs8030605 RFX7 A -0.06 0.08 -0.22 0.10 0.4367 -0.02 0.09 -0.20 0.16 0.7990 -0.17 0.18 -0.52 0.19 0.3557 0.3421
rs2165295 SMAD6 A -0.03 0.06 -0.14 0.08 0.6061 0.00 0.07 -0.14 0.13 0.9780 -0.13 0.11 -0.34 0.08 0.2326 0.4241
rs2925979† CMIP T 0.04 0.05 -0.07 0.15 0.4459 0.09 0.06 -0.04 0.22 0.1651 -0.07 0.10 -0.27 0.13 0.4863 0.1259
rs4646404 PEMT G -0.12 0.06 -0.23 -0.01 0.0305 -0.13 0.07 -0.26 0.00 0.0461 -0.09 0.10 -0.29 0.11 0.3696 0.7364
rs12454712 BCL2 T -0.03 0.05 -0.13 0.07 0.5588 -0.03 0.06 -0.15 0.09 0.6689 -0.10 0.10 -0.30 0.10 0.3181 0.7877
rs4531856 JUND C -0.01 0.05 -0.12 0.10 0.8775 0.02 0.06 -0.10 0.14 0.7216 -0.16 0.12 -0.38 0.07 0.1799 0.3273
rs4081724† CEBPA G 0.05 0.08 -0.11 0.21 0.5480 0.06 0.09 -0.13 0.24 0.5457 -0.02 0.15 -0.32 0.28 0.9015 0.9190
rs979012† BMP2 T 0.01 0.06 -0.10 0.12 0.8866 -0.01 0.07 -0.14 0.12 0.8766 0.09 0.11 -0.12 0.29 0.4144 0.5297
rs224333 GDF5 G -0.03 0.05 -0.13 0.08 0.6297 -0.06 0.06 -0.18 0.06 0.3179 0.09 0.11 -0.12 0.30 0.4072 0.1354
rs6090583 EYA2 A -0.02 0.06 -0.13 0.09 0.7381 0.01 0.06 -0.11 0.14 0.8178 -0.09 0.12 -0.31 0.14 0.4667 0.4072
rs4823006 ZNRF3-KREMEN1 A -0.03 0.06 -0.14 0.08 0.5498 -0.02 0.07 -0.15 0.11 0.7787 -0.07 0.11 -0.28 0.14 0.5242 0.6126
Where: EA, effect (WHRadjBMI-increasing) allele thus a positive beta is consistent with the previous publications; L95, lower boundry of 95% conﬁdence
interval; U95, upper boundry of 95% conﬁdence interval
*, effects sizes the same as those previously reported
†, effect directions consistent with those previously reported (Shungin et al, 2015). Analyses adjusted for sex, age, age2 and BMI. Pinter, P for sex
interaction.
doi:10.1371/journal.pone.0153990.t006
Fat Distribution Loci and Adipocyte Lipolysis
PLOS ONE | DOI:10.1371/journal.pone.0153990 April 22, 2016 9 / 12
functions of abdominal subcutaneous adipocytes. If central fat accumulation is driving the
spontaneous or stimulated adipocyte lipolysis, then the SNPs robustly associated with central
fat accumulation would be expected to have a similar effect on lipolysis. Whilst the SNP score
analysis does not fulfil the criteria for a true Mendelian randomisation experiment (because the
WHRadjBMI-associated SNPs do not show the expected associations with WHRadjBMI), it
does provide novel evidence to suggest that, generally speaking, genetically-determined central
fat accumulation has little effect on adipocyte lipolysis. A direct test of the reverse hypothesis
that adipose lipolysis capacity determines central fat accumulation is unfortunately not yet
possible.
The nominal associations between specific tagging SNPs identified by WHRadjBMI GWAS
and lipolysis measures reported here, although becoming nonsignificant after adjustment for
multiple testing. highlights potential novel biology as none of the candidate genes suggested by
Shungin et al (6) for these loci are established regulators of lipolysis [20].
Firstly, effects on NFκB signalling. CMIP has been reported to influence NFκB signalling
[21] which in turn can modulate adipocyte lipolysis [22]. Recently our group has demonstrated
that CMIP expression levels were negatively associated with insulin-stimulated lipogenesis in
subcutaneous adipocytes [23]. The observation here that the rs2925979 CMIP locus is also
associated with spontaneous and dcAMP-stimulated lipolysis extends mechanistic understand-
ing of this locus.
Secondly, effects on adipocyte morphology. PLXND1 has been shown to regulate adipose
morphology, i.e. the relationship between adipocyte size and number (24), with a genetic defi-
ciency demonstrating reduced fat mass [24]. In light of the fact that spontaneous lipolysis is
strongly correlated with adipocyte size, as previously discussed [10], the WHRadjBMI-increas-
ing allele of rs10804591 in the PLXND1 locus demonstrating a positive association with
increased spontaneous lipolysis is intriguing. Furthermore, the WHRadjBMI-increasing allele
of rs6905288 in the VEGFA locus revealed a positive correlation with isoprenaline-stimulated
lipolysis. Interestingly, expression of VEGFA in adipose tissue has been shown to have benefi-
cial metabolic effects via proangiogenic activity during adipose tissue expansion [25].
As for KREMEN1 and ZNRF3, associated here with both dcAMP- and isoprenaline-stimu-
lated lipolysis, both are involved in Wnt signalling, which inhibits adipogenesis [26–28]. Con-
sidering that that WHRadjBMI is inversely associated with stimulated lipolysis, it is surprising
that the WHRadjBMI increasing allele at the VEGFA and KREMEN1-ZNRF3 loci are associ-
ated with increased stimulated lipolysis. This raises the question whether these are spurious
associations.
Whilst the cohort studied here is unique regarding the relatively large number of subjects
with specific adipocyte lipolysis measures, there are some limitations to this study. Incomplete
genotyping, finally including 40 of 49 reported WHRadjBMI-associated loci, means that the
SNP score does not fully represent genetically-determined fat distribution. Also, for some
SNPs we cannot confirm reported GWAS associations with WHRadjBMI [6], adding some
uncertainty to our conclusion that WHRadjBMI does not regulate adipose lipolysis. The nomi-
nal genetic associations reported here were became nonsignificant after adjustment for multi-
ple testing and would therefore benefit form replication in an independent cohort.
Unfortunately there is as far as we know no replication cohort available. Despite the shortfalls
of this study, we believe that the findings are relevant since we used established genetic associa-
tions to select the SNPs and based the study on a hypothesis that was experimentally validated,
i.e. the association reported here between measures of obesity and lipolysis.
In summary, this study shows nominal significant associations between specific central obe-
sity loci and measures of lipolysis functions in abdominal subcutaneous adipose tissue but
refutes genetically increased central fat accumulation as a main cause of altered lipolysis.
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Whilst generally weak associations were observed, our findings suggest that the mechanisms
by which genetic variants influence central fat accumulation are diverse and locus-specific.
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